Popular weight-loss jabs cure mystery condition
It affects millions. You can live with it for years without even knowing. A slow-moving condition that creeps in through unhealthy habits and grows silently inside.
No visible symptoms. No early alarms. And no approved cure. Until now.
An old drug with a new twist
Researchers at King’s College London have just discovered something startling.
They tested semaglutide – the key ingredient in the widely used jabs Wegovy and Ozempic – on 800 people suffering from a fatty liver disease.
For 18 months, these patients received the injections as part of a clinical trial.
An astonishing 63 % saw a reduction in inflammation and fat build-up in their liver – a vital organ often overlooked until it’s too late.
They also showed better blood results – and lost an average of nearly 11 % of their body weight. But it’s what happened inside their bodies that truly matters.
The surprising truth about these jabs
These jabs were originally developed to help people with type 2 diabetes. Later, they made headlines for causing dramatic weight loss by suppressing appetite.
But now, scientists have found that semaglutide’s effect goes further than anyone expected.
It’s not just a fat-buster. It appears to restore balance in places weight loss alone could never reach.
According to study leader Professor Philip Newsome, this discovery offers new hope for people suffering from a condition that, until now, had no real medical solution.
While more research is needed, the early results are promising – and could change how this silent disease is treated in the future.
This article is based on information from The Sun.
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.